
2.87 Delayed Data As of Feb 01 | ![]() Today’s Change | 1.79 Today|||52-Week Range 15.00 | +21.10% Year-to-Date |
The 1 analysts offering 12-month price forecasts for Aileron Therapeutics Inc have a median target of 40.00, with a high estimate of 40.00 and a low estimate of 40.00. The median estimate represents a +1,293.73% increase from the last price of 2.87.
The current consensus among 4 polled investment analysts is to Hold stock in Aileron Therapeutics Inc. This rating has held steady since July, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.